Quad Capital Management Advisors’s Chembio diagnostics, Inc. CEMI Stock Holding History

Quad Capital Management Advisors’s Portfolio CEMI Stock Details CEMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-13,372	Closed	-$82K	–	81
2019 Q3	$82K	Buy	+13,372	New	+$79.7K	0.04%	73

Other funds holding CEMI

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return

Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Quad Capital Management Advisors's CEMI Position: Q4 2019 in Review

Quad Capital Management Advisors sold out of Chembio diagnostics, Inc. (CEMI) in Q4 2019, closing a stake of 13,372 shares — an estimated $82K sold.

Quad Capital Management Advisors first reported a position in CEMI in Q3 2019 and held it in 1 quarter. The position peaked at $82K in Q3 2019. 39 funds tracked by Wall St. Rank hold CEMI as of Q4 2019.

Quad Capital Management Advisors reported no remaining Chembio diagnostics, Inc. position as of Q4 2019 after selling out during the quarter.
Quad Capital Management Advisors sold 13,372 Chembio diagnostics, Inc. shares in Q4 2019, an estimated $82K.
Quad Capital Management Advisors first reported a position in Chembio diagnostics, Inc. in Q3 2019 and held it in 1 quarter.
Quad Capital Management Advisors's Chembio diagnostics, Inc. position peaked at $82K in Q3 2019.
39 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q4 2019.

Based on Quad Capital Management Advisors's 13F filing for Q4 2019, filed 9 Jan 2020.